Clinical Trial Update: The Effect of Lactobacillus Reuteri ATCC PTA 6475 on Volumetric Bone Mineral Density in Patients With Osteopenia [NA]

View source ↗

Summary

The trial evaluates whether Lactobacillus reuteri ATCC PTA 6475 impacts volumetric bone mineral density in adults with osteopenia; the study status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteopenia

Drugs mentioned

• Lactobacillus reuteri ATCC PTA 6475 (Lactobacillus reuteri ATCC PTA 6475)

Snippet

Sponsor: Sahlgrenska University Hospital | Conditions: Osteopenia | NA | Status: COMPLETED